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methodsAbstract The ﬂoating beads have been employed to make a sustained release of the drug in the
stomach and to decrease the dose of the drug and hence overcome its side effects. The common ben-
eﬁts of the ﬂoating beads were it is easy preparation, without the need of a high temperature, and
high percentage of the drug entrapment. In the present work, the Ketorolac tromethamine (KT)
ﬂoating beads were prepared by extrusion congealing method utilizing calcium carbonate as a
gas forming agent. The physical characters of the produced beads were investigated such as KT
yield, KT loading, and entrapment efﬁciency of the drug. In addition, ﬂoating behavior, swelling,
particle size, morphology and KT stability were also evaluated. In vitro drug release study was car-
ried out, and the kinetics of the release was evaluated using the linear regression method. Further-
more, the in vivo analgesic effect of KT after oral administration of the selected formula of ﬂoating
beads (F10) was carried out using hot plate and tail ﬂick methods. Oral commercial KT tablets and
KT solution were used for the comparison. The prepared beads remained ﬂoated for more than 8 h.
The optimized formulation (F10) exhibited prolonged drug release (more than 8 h) and the drug
release follows the Higuchi kinetic model, with a Fickian diffusion mechanism according to Kors-
meyer-Peppas (n= 0.466). Moreover, F10 showed a sustained analgesic effect as compared to the
commercial tablet.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Gastric residence time is an important parameter for different
dosage forms and the prolongation and control of this time,
epically for the dosage forms which remain in the stomach
for a longer period of time result in better absorption and en-
hanced bioavailability. Gastro-retentive drug delivery systems
are systems that can reside in the gastric region for several
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idence time of drugs. Prolonged gastric retention enhances bio-
availability and improves solubility for drugs that are less
soluble in high pH environment. Moreover, gastro-retention
has application for local drug delivery to the stomach and
proximal small intestines and also has substantial advantages
for patients (Alexander and Juergen, 2006; Arora et al.,
2005). Floating drug delivery systems are low density, matrix
type systems designed by the addition of some polymers such
as cellulose derivatives, polysaccharides, carbopol and chito-
san and different effervescent components like sodium bicar-
bonate, calcium carbonate, citric acid or tartaric acid. These
ﬂoating dosage forms are formulated in such a way that when
they come in contact with gastric content, carbon dioxide is re-
leased and is entrapped in the hydrocolloids which makes the
dosage forms to ﬂoat (Gangadharappa et al., 2007). When the
system is ﬂoating on the gastric juice, the drug is released
slowly and this results in an increased gastric residence time
and a better control of the variability in plasma drug concen-
tration. Alginate beads have been designed in the present study
as vehicle for drug delivery systems. Alginate is a hydrophilic
polymer, stable in acidic media and easily depredated in alka-
line media. These properties have enabled widespread use of
alginate beads in gastro-retentive dosage forms (GRDFs) for
sustained release of drugs (Gadad et al., 2009). Ketorolac tro-
methamine (KT) is a potent non-steroidal anti inﬂammatory
drug with biological half-life ranged from 4 to 6 h and it is
mainly absorbed in the proximal part of the small intestine
(Sinha and Trehan, 2005). KT is 800 times more potent than
aspirin and produces strongly analgesic and moderate anti-
inﬂammatory activity (Padma et al., 2000). The main principle
of ﬂoating beads can be applied to decrease the irritant effect
of KT on the stomach by avoiding the direct contact with
the gastric mucosa and obtaining a low dosage for prolonged
periods (Thanoo et al., 1993). The aim of the present work is
to prepare KT in different ﬂoating calcium alginate beads to
control the drug release using calcium carbonate as a gas form-
ing agent. The inﬂuence of hydroxylpropyl cellulose, sodium
carboxymethyl cellulose, methyl cellulose and pectin as hydro-
philic co-polymers on percentage loading of drug, entrapment
efﬁciency, swelling, ﬂoating, particle size and in vitro drug re-
lease was studied. Furthermore, the analgesic effect of the drug
using tail ﬂick and hot plate methods was investigated.
2. Materials and methods
2.1. Materials
Ketorolac tromethamine (KT) was purchased from (Varda
Biotech Ltd., India). Sodium alginate, pectin, calcium carbon-
ate and glacial acetic acid were obtained from (BDH, UK).
HPMC, MC, HPC and Na CMC were obtained from (DOW
Chemicals, UK). Ketoral was purchased from (Al-Arab
Drug Company, Egypt). All other reagents used were of ana-
lytical grade.
2.2. Methods
2.2.1. Formulation of KT ﬂoating beads
Stock solution of KT was prepared by dissolving 40 mg in 5 ml
of water. The KT solution then was added to 95 ml sodiumalginate solution, (3% w/v) containing methyl cellulose
(MC), hydroxypropyl cellulose (HPC), sodium carboxymethyl
cellulose (Na CMC), and pectin as co-polymers in ratio of
(alginate: copolymer, 9:1, 7:1, and 5:1 w/w). Calcium carbon-
ate was added to sodium alginate solution in a ratio of 1:1
and the mixture dropped using 24 G syringe needle into
100 ml of calcium chloride solution (1% w/v) which contains
glacial acetic acid (10% v/v). Then the beads formed in the
solution were stirred for 10 min to improve its hardness. After
that the beads were collected and washed with distilled water,
then dried for 48 h. The different formulations of KT are pre-
sented in Table 1.
2.3. Characterization of KT ﬂoating beads
2.3.1. Determination of percentage yield, drug loading (DL) and
encapsulation efﬁciency of the prepared beads
- Percentage yield for the formulated beads was calculated
from the following equation (Prasad et al., 2011):
Yield% ¼Weight of the beads=weight of drug
þ polymer weight 100
- Determination of drug loadingTwenty-ﬁve milligrams were weighed of the KT prepared
beads and were dissolved in 50 ml of buffer pH 1.2 centrifuged,
ﬁltered and then the ﬁlterate was analyzed at 322 nm using a
UV/visible spectrophotometer (Thermospectronic, USA).
The experiment was carried out in triplicate and drug loading
was calculated from the following equation (Prasad et al.,
2011):
Drug loading ¼Weight of drug in beads=Total weight of beads
 100
Percentage encapsulation efﬁciency was calculated using the
following formula:
- The encapsulation efﬁciency was determined from the fol-
lowing equation = actual amount of drug (AQ)/theoretical
amount of drug (TQ) · 100 Prasad et al., 2011.
2.3.2. Scanning electron microscope (SEM)
The prepared ﬂoated beads were examined for its surface mor-
phology by SEM (Metler Toledo, Tokyo, Japan). The samples
were ﬁxed in individual stubs and coated uniformly with gold.
2.3.3. Determination of particle size
Average particle size of beads was determined using sieve anal-
ysis method. Twenty gram beads were weighed carefully and
placed on the ﬁrst screen and shaken for certain time. Each
fraction is then taken and weighed. The particle size was deter-
mined as follows:
dave: ¼
X
nd=
X
n
where, dave. is the average diameter of beads, n is percent of
each fraction retained on each sieve and d is the arithmetic
Table 1 Composition of different KT ﬂoating beads.
Formulae code Formulae composition (% w/w)
KT (mg) Sodium alginate (SA) MC Na CMC HPC Pectin CaCO3 CaCl2
F1 40 3.000 – – – – 3.00 1.00
F2 40 2.700 0.300 – – – 3.00 1.00
F3 40 2.625 0.375 – – – 3.00 1.00
F4 40 2.500 0.500 – – – 3.00 1.00
F5 40 2.700 – 0.300 – – 3.00 1.00
F6 40 2.625 – 0.375 – – 3.00 1.00
F7 40 2.500 – 0.500 – – 3.00 1.00
F8 40 2.700 – – 0.300 – 3.00 1.00
F9 40 2.625 – – 0.375 – 3.00 1.00
F10 40 2.500 – – 0.500 – 3.00 1.00
F11 40 2.700 – – – 0.300 3.00 1.00
F12 40 2.625 – – – 0.375 3.00 1.00
F13 40 2.500 – – – 0.500 3.00 1.00
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ment was performed in triplicate.
2.3.4. Determination of swelling properties
Known weight (50 mg) of ﬂoated beads was soaked in 100 ml
of buffer 1.2 pH at 37 ± 0.5 C. Then the beads were removed
at speciﬁed time intervals, dried and weighed to determine the
swelling index. Swelling ratio was determined from the follow-
ing equation:
Swelling ratio = (weight of swollen beads – initial weight of
beads)/initial weight of beads (Yagnesh et al., 2006). The
experiment was performed in triplicate and the average results
were taken.
2.3.5. Determination of lag and buoyant time
Speciﬁed weight (50 mg) of ﬂoated beads was placed in a bea-
ker containing 100 ml of buffer 1.2 pH and shaked at 50 rpm
in a water bath 37 ± 0.5 C. The time taken by beads to ﬂoat
on the surface was determined (lag time). The layer of the
ﬂoated beads was removed and the layer at the bottom was
separated by ﬁltration. The upper and the lower layers were
dried at 40 C until constant weight. Buoyant time was calcu-
lated by the following equation:
ð%Þfloating¼weight of floated beadsðWfÞ=weight of floated beadsðWfÞ
þweight of settled beadsðWsÞ100
(Stops et al., 2008). All the determinations were made in
triplicate.
2.3.6. In-vitro release study
The dissolution rate of the prepared beads was studied using
USP rotating paddle dissolution apparatus II (Erweka DT-
600 GmbH, Germany). Known weight of beads containing
equivalent amount of 10 mg of KT was placed in the dissolu-
tion medium (900 ml of buffer pH 1.2). The temperature was
adjusted to 37 ± 0.5 C at 50 rpm. 5 ml of samples was with-
drawn at speciﬁed time intervals and replaced with fresh disso-
lution medium. The samples were ﬁltered with 0.45 lm
Whatmanmembrane ﬁlter and the quantity of the drug released
was determined using spectrophotometrically at 322 nm. The
release rate of 10 mg of KT powder and KT commercial tablets
(Ketoral 10 mg) was determined. The experiment was carriedout in triplicate and the average values of the released amount
were calculated and plotted versus time. The results were ex-
pressed as the percentage of cumulative amount released as a
function of time.
2.3.7. Kinetic study
The release data were analyzed using different kinetic equa-
tions which include Zero-order, First-order kinetics, Higuchi
diffusion and Korsmeyer-Peppas models (Martin et al., 1993).
2.3.8. Stability study
The stability of Kt ﬂoating beads was studied at 25 C and
60% relative humidity in closed high-density polyethylene bot-
tles for 6 months. The drug content and the ﬂoating behavior
were determined at different time intervals such as 1, 2, 3, and
6 months.
2.3.9. Analgesic effect study
The in vivo analgesic effect of selected KT ﬂoating beads’ for-
mula (F10) was investigated. It was assessed by two different
methods; hot plate and tail ﬂick models.
2.3.9.1. Animals. Five groups of Swiss-albino male and female
mice weighing 30–40 g were used for each formula; each group
consists of sixmice.Group Iwas used as a control, which received
1 ml saline, group II received KT solution, while group III re-
ceived KT commercial tablets (Ketoral) and, ﬁnally groups
IV and V were given the selected KT ﬂoating beads (F10) in fast
and fed state respectively. Foodwas withdrawn 12 h before start-
ing the experiment for all groups except for the ﬁfth group; which
was kept on standard laboratory diet and tap water and the ani-
mals were kept at room temperature. All the experiments were
carried out according to the ethical guidelines established and ap-
proved by the committee on the use and care of laboratory ani-
mals of our university (Saleem et al., 2011).
2.3.9.2. Calculation of KT dose. For the solution of KT, com-
mercial KT tablets (Ketoral) and selected KT ﬂoating beads
(F10), the dose level of 1.1 mg/kg of the drug corresponding to
10 mg human dose was used. This equivalent dose for mice was
calculated by the aid of surface area ratio as; the therapeutic
dose of human was multiplied by a certain mathematical factor
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common laboratory species and man (Ghosh, 1971). The fol-
lowing equation was used: Dm = Dh (Wm/Wh)
3/4 where, Dm:
mice dose; Dh: human dose; Wm: mice weight; Wh: human
weight (Geoffrey and James, 2005).
2.3.9.3. Hot plate method. The mice were placed on hot plate
analgesiameter (MK-350 D, Japan) adjusted to temperature
51 ± 1 C, where the surface is hot enough to cause discom-
fort without tissue damage. The mice were received orally
the calculated KT dose (1.1 mg/kg) thirty minutes before the
beginning of the test. The time taken till the mice begin to
jump or lick forepaw was determined and this time was called
the reaction time. Each trial was not taking more than 25 s to
avoid tissue damage. The reaction time of the analgesic effect
was measured at 0.5, 1, 2, 3, 4, 5, 6, 7, and 8 h and the changes
in the behavior of mice in the presence of KT were detected in
fast and fed mice. The effect of food on the duration of anal-
gesic effect was also determined (Amberkar et al., 2011).
2.3.9.4. Tail ﬂick method. Mice were placed on tail ﬂick appa-
ratus, analgesia meter (MK-350 D, Japan) using simple re-
strain device to ﬁx the animal for testing. The tail was placed
into a sensing groove and a photo-sensor was located under
this groove. The beam that produces the radiant heat stimulus
was focused on the area of the distal part of the tail and the
strength of the radiant heat lamp was kept constant. The time
taken by mice to withdraw the tail was measured and this time
was called the reaction time of the analgesic effect. Cut-off
reaction time was 10 s to avoid any tissue injury. Then the
same procedure of the hot plate method was carried out (Ibra-
him et al., 2010).
2.4. Statistical analysis
All results were expressed as mean values ± standard devia-
tion (SD) for in vitro results and as means ± SE for in vivo re-
sults. One-way analysis of variance (ANOVA) test followed by
the Duncan’s multiple comparison tests were used. A probabil-Table 2 Percentage yield, drug loading %, drug encapsulation efﬁci
% after 8 h of KT ﬂoating beads.
Formulae code Yield (%) Drug loading (%) Drug enca
eﬃciency
Physicochemical characterization
F1 80.0 ± 4.0 56.9 ± 3.6 45.00 ± 1
F2 84.5 ± 2.3 88.5 ± 4.8 70.25 ± 2
F3 86.5 ± 2.0 73.2 ± 6.3 73.25 ± 2
F4 87.0 ± 2.6 86.1 ± 5.9 85.50 ± 1
F5 83.5 ± 2.5 78.5 ± 3.6 64.25 ± 2
F6 84.0 ± 3.6 82.3 ± 7.1 67.50 ± 1
F7 85.0 ± 1.7 82.3 ± 6.5 69.00 ± 1
F8 89.0 ± 2.7 88.5 ± 3.6 78.00 ± 1
F9 90.0 ± 3.6 90.0 ± 5.7 80.00 ± 1
F10 94.5 ± 1.5 92.3 ± 4.4 86.75 ± 3
F11 81.0 ± 2.0 73.1 ± 3.2 58.25 ± 1
F12 82.5 ± 1.5 74.6 ± 4.8 61.00 ± 1
F13 83.0 ± 2.5 77.0 ± 3.1 63.25 ± 1
All values are mean ± SD of three determinations.ity value less than 0.05 was considered to be a signiﬁcant value
(Bolton and Bon, 2004).
3. Results and discussion
The data of physicochemical characterization include percent-
age yield, drug loading, drug encapsulation efﬁciency, mean
particle size, ﬂoating lag time and % ﬂoating after 8 h of all
KT formulations and are represented in Table 2. The percent-
age yield of ﬂoating beads ranged from 80% to 94.5% for F1
and F10 respectively. Results showed that; yield increased by
increasing co-polymer concentration and with respect to co-
polymer type; beads composed of sodium alginate/HPC
(F10) showed the highest yield (94.5%) while those composed
of sodium alginate/pectin (F13) showed the lowest one(83%).
3.1. Drug loading and encapsulation efﬁciency
The% drug loading of various beads was ranged from 56.9%
to 92.3% for F1 and F10, respectively, while the % encapsula-
tion efﬁciency was 45.0% for (F1) and 86.75% for (F10). Re-
sults indicated that the drug loading and encapsulation
efﬁciency were low for beads composed of sodium alginate
(F1), while it was increased signiﬁcantly by the addition of an-
other co-polymer to alginate, which increased its ability to re-
tain the drug by the formation of two types of protective layers
in beads and delayed the diffusion of the drug more effectively
than a single protective layer formed by sodium alginate (Ajit
et al., 2006). In addition the use of pectin showed the lowest
KT loading and encapsulation efﬁciency when compared with
the other used co-polymers which may be due to that pectin
did not increase the viscosity of hydrogel matrix and the cal-
cium pectinate layer did not prove effective in prevention of
the diffusion of the drug (Yang et al., 2000). Furthermore,
the results showed that the drug loading and encapsulation
efﬁciency were dependent on the type and concentration of
co-polymer used in the formulation (Sriamornsak et al.,
2007). Co-polymers could be arranged according to its ability
to encapsulate the drug in the following order: HPC >ency %, mean particle size, density, ﬂoating lag time and ﬂoating
psulation
(%)
Mean particle
size (lm)
Floating lag
time (s)
Floating (%)
after 8 (h)
.7 711 ± 14.50 41.0 ± 1.70 95 ± 5.60
.1 825 ± 19.90 86.0 ± 4.40 92.5 ± 6.8
.0 907 ± 17.00 95.0 ± 6.00 90.4 ± 7.6
.5 1005 ± 22.9 120 ± 10.5 91 ± 6.60
.1 860 ± 25.00 90.0 ± 5.60 93.6 ± 2.5
.5 975 ± 22.90 110 ± 9.50 91.2 ± 2.3
.7 1112 ± 13.1 140 ± 12.5 92.1 ± 3.5
.8 1000 ± 21.8 83.0 ± 6.10 88.5 ± 4.0
.0 1130 ± 13.2 95.0 ± 7.0 86 ± 4.00
.2 1260 ± 22.7 125 ± 9.5 86.5 ± 2.9
.1 710 ± 18.00 45.0 ± 4.40 96 ± 1.00
.0 780 ± 31.20 53.0 ± 4.40 95.5 ± 2.5
.2 801 ± 18.40 50.0 ± 2.00 95 ± 2.00
Figure 1 Scanning electron microphotographs of different formulations of KT ﬂoating beads. (a) F1, (b) F2, (c) F5, and (d) F10.
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the viscosity of the polymer used, as the viscosity increased,
the diffusion of the drug from the beads decreased.
3.2. SEM of ﬂoating KT beads
The SEM pictures for various preparations of KT ﬂoating
beads are given in Fig. 1. SEM photographs of beads showed
that beads had oval, disk or spherical shape with a uniform
texture and smooth surface. The smooth surface was due to
the use of optimum concentration ratio of calcium carbonate
to sodium alginate (1:1 w/w) as a gas forming agent for the
bead formation. The result coincident with the report of
Shishu et al., 2007 who studied the effect of various concentra-
tion ratios of calcium carbonate and sodium alginate on the
morphology of the surface of beads (Shishu et al., 2007).
3.3. Study of particle size
Particle size of the ﬂoating KT beads was affected by the con-
tent of co-polymer used and its ratio in relation to alginate in
the formulation. The average particle size of the KT ﬂoating
beads markedly increased with increasing co-polymer concen-
tration and it was in the range from 711 to 1260 lm (Table 2).
With respect to the effect of co-polymer type on size of beads,
co-polymers could be arranged as follows: HPC >NaCMC>MC> pectin. This may be related to differences in
the molecular weight and structure of co-polymers which re-
sults in polymeric solutions of different viscosities (Gattani
et al., 2009).
3.4. Swelling characteristics of KT ﬂoating beads
The swelling behavior of beads as expressed in terms of swell-
ing ratio was done by incubating beads in 1.2 pH buffer at
37 C for 8 h. All formulated KT beads remained intact in
1.2 pH buffer during the experimental time and appeared more
transparent due to the conversion of ca-alginate into alginic
acid gel. A reduction in gel strength appeared following the
conversion of ca-alginate into alginic acid gel. This may be
due to the weaker hydrogen bonds cross linking in alginic acid
which leads to the absorption of high quantity of water, swell-
ing and increasing in size (Draget et al., 2005). In general, it
was evident that, the swelling ratios increased by increasing
co-polymer concentration but this increase was not statistically
signiﬁcant (p> 0.05) for all co-polymers used (Figs. 2–5). F11
showed the lowest equilibrium swelling ratio, 2.5 while F10
showed the highest swelling ratio value about 5.5 at the end
of 8 h. Beads containing HPC showed the highest swelling ra-
tio than the other beads due to the hydrophilic nature of the
cellulose derivative polymers, also the presence of hydroxyl
group in the molecules which plays a signiﬁcant role in the
00.5
1
1.5
2
2.5
3
3.5
4
4.5
0 2 4 6 8 10
Sw
el
lin
g 
ra

o
Time (hours)
F-1 control
F-2
F-3
F-4
Figure 2 Swelling ratios of KT ﬂoating beads, SA/MC (F2–F4)
in 0.1 N HCl (pH 1.2).
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Figure 3 Swelling ratios of KT ﬂoating beads-SA/Na CMC-
(F5–F7) in 0.1 N HCl (pH 1.2).
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Figure 5 Swelling ratios of KT ﬂoating beads of SA/Pectin
(F11–F13) in 0.1 N HCl (pH 1.2).
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Figure 4 Swelling ratios of KT ﬂoating beads, SA/HPC (F8–
F10) in 0.1 N HCl (pH 1.2).
354 A.E.S.F. Abou el Ela et al.water uptake and in the matrix integrity of swollen polymer
(Borkar et al., 2010). From Fig. 6, the co-polymers used could
be arranged in the following ranked order according to theirswelling ratios after 8 h in 0.1 N HCl as follows: HPC > Na
CMC>MC> pectin.
3.5. Floating studies
The results showed that all prepared beads had lag time from
41 to 140 s and also from 86.4% to 96% of beads remained
ﬂoated for 8 h. According to the percentage of beads ﬂoated
after 8 h; co-polymers, could be arranged in the following rank
order: pectin > Na CMC>MC>HPC (Table 2).
3.6. In vitro release studies
In vitro drug release experiments were done to examine the
probability of employing sodium alginate in combination with
the different co-polymers as matrix for intra-gastric ﬂoating
drug delivery, also, to evaluate the applying of four different
co-polymers in three different concentrations on drug release.
Release proﬁles are represented in (Figs. 7–11) by plotting
the percent cumulative amount of drug released in 1.2 pH buf-
fer against time. The inﬂuence of co-polymer concentration on
the release rate of KT may be due to the decrease in total
porosity of the matrices (initial porosity plus porosity due to
drug dissolution) (Boza et al., 1999) and hence an increase in
the hydrophobicity which decreases the diffusion of the drug
from this matrix (Tiwari et al., 2003). 100% of KT was re-
leased from the KT powder and commercial KT tablets
(Ketoral) in about 50 and 85 min, respectively, while the
release of KT from ﬂoating beads sustained for a long time
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Figure 8 Release proﬁles of KT from ﬂoating beads (F2–F4),
KT powder and Ketoral in 0.1 N HCl (pH 1.2).
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Figure 9 Release proﬁles of KT from ﬂoating beads (F5–F7),
KT powder and Ketoral in 0.1 N HCl (pH 1.2).
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formula. From the obtained data it was concluded that, the
lower the concentration of sodium alginate in ﬂoating beads,
the lower is the rate of drug release from the beads (except
for pectin containing beads, F11–F13). It was observed that
100% of drug was released from F1 within ﬁve hours
(Fig. 7); this may be due to the large mesh size of sodium algi-
nate matrix, which allows the rapid diffusion of the dissolution
media into gel matrix, dissolving drug and outward release of
the dissolved drug (Borkar et al., 2010). So F1 did not show
the expected sustained release characteristics and drug was re-
leased within ﬁve hours. In order to sustain the release of the
drug; co-polymers were added to increase the encapsulation0
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Figure 10 Release proﬁles of KT from ﬂoating beads (F8-efﬁciency and modifying the mode of release of KT from the
beads.
F2, F3 and F4 containing (9:1, 7:1, and 5:1) ratios of so-
dium alginate: methylcellulose respectively (Fig. 8) showed
only slight prolongation of drug release when compared to
F1 with a non signiﬁcant difference in retardation of the re-
lease (p> 0.05). Also there was no signiﬁcant (p> 0.05) retar-
dation in drug release in F4 when compared with F3 and F2.
Methylcellulose (MC) is a cellulose ether in which the methyl
group has been substituted for the hydroxyl group on the
2-glucopyranose residues and it has been reported that the
MC has the ability to increase the degree of agglomeration
of alginate beads (Raju et al., 2010; Chan et al., 1997). This
may result in the formation of more rigid gel structure around
the drug particles leading to more encapsulation efﬁciency
while in acidic media protonation of ether linkage of MC leads
to decrease in the rigidity of MC molecules. These results were
in agreement with those obtained by El-Kamel et al. (2003)
who found that the addition of MC to alginate resulted in a
non signiﬁcant difference in the release rate of diltiazem in
0.1 N HCl.
Fig. 9. shows that F5, F6 and F7 containing sodium algi-
nate/Na CMC in ratios 9:1, 7:1 and 5:1, respectively, have
more retardation in drug release when compared with F1,
and the retardation was non signiﬁcant (p> 0.05) when com-
pared F6 and F7 with F5. F6 and F7 showed retardation of
drug release, about 85% and 80% of the drug were released
within 8 h from the two formulae, respectively. The increase
in polymer concentration; increases the viscosity and swelling
of the polymer matrix as well as the formation of the water-
swollen gel with longer diffusion path length that could sub-
stantially reduce the penetration of the dissolution medium
into the beads and so the drug release was retarded (Kamel
et al., 2008).
In the case of F8, F9 and F10, the replacement of part of
sodium alginate with HPC showed a signiﬁcant decrease in
drug release rate when compared to F1 and about 50–60%
of a drug released within 8 h (Fig. 10). This can be attributed
to the low solubility of HPC, which is soluble in water only at a
temperature below 38 C, also HPC produces water-swollen
gel that could substantially reduce the penetration of dissolu-
tion medium into the beads and so the drug release was re-
tarded. Moreover, by increasing the amount of HPC (F9 &
F10) the rate of drug release decreased but this decrease was
not signiﬁcant at p< 0.05 when compared to F8.
The use of combinations of sodium alginate with pectin in
F11, F12 and F13 (Fig. 11) showed no retardation in the drug0 360 420 480
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F-10
KT powder
Ketoral®
F10), KT powder and Ketoral in 0.1 N HCl (pH 1.2).
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Figure 11 Release proﬁles of KT from ﬂoating beads (F11–F13),
KT powder and Ketoral in 0.1 N HCl (pH 1.2).
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released within 5 h. Pectin has the ability to form gel with diva-
lent cations and has been used in the production of calcium
pectinate which used for retardation of drug release, but in this
study the incorporation of pectin together with alginate ap-
pears to inﬂuence the degree of cross-linking of alginate with
calcium ions and no retardation in drug release was obtained
(Pillay and Fassihi, 1999). From the results; it was concluded
that ﬂoating beads containing HPC (F10) gave the highest
swelling ratio (5.5) after 8 h (Fig. 2) and also gave the slowest
in vitro release of KT (Fig. 7).
Hence, the release rate of the drug from the ﬂoating beads
can be governed by the type and concentration of co-polymer
employed in the preparation of the beads. All formulated
beads except F1, F11, F12 and F13 showed retardation in
the release of drug from beads with different extents depending
on the co-polymer used. The rank order for the rate of drug
released from the ﬂoating beads in 0.1 N HCl (pH 1.2) accord-
ing to the co-polymer type was as follows: HPC < Na
CMC<MC< Pectin, when compared with alginate beads.
3.7. Kinetic studies of drug release
In order to determine the release mechanism that provides the
best description to the pattern of drug release; data of the
in vitro release of all formulae (F1–F13) were ﬁtted to different
kinetic models. The kinetic models used were zero, ﬁrst-order,
Higuchi diffusion and Korsmeyer-Peppas models. The kineticTable 3 Kinetic parameters of KT release data according to differ
Formulae code Zero-order First-order
R2 K0 (% min
1) R2 K1 (m
F1 0.880 0.178 0.905 0.002
F2 0.974 0.174 0.871 0.001
F3 0.965 0.151 0.822 0.001
F4 0.951 0.166 0.848 0.002
F5 0.946 0.170 0.800 0.001
F6 0.934 0.174 0.702 0.001
F7 0.945 0.174 0.743 0.001
F8 0.895 0.085 0.755 0.001
F9 0.920 0.089 0.760 0.001
F10 0.907 0.087 0.711 0.001
F11 0.957 0.249 0.792 0.002
F12 0.923 0.198 0.765 0.001
F13 0.936 0.195 0.770 0.002rate constant (k) and the determination coefﬁcient (R2) were
calculated and are presented in Table 3. The best ﬁt with the
highest determination coefﬁcient (R2) for all formulae was
shown with Higuchi diffusion model followed by Peppas re-
lease model and then zero-order equation. These results re-
vealed that the kinetic release pattern was best ﬁtted to
Higuchi equation which describes drug release from a poly-
meric system by diffusion mechanism. Fickian diffusion mech-
anism of release (n< 0.5) was the drug release controlling
mechanism for all formulae; except for F4, F7 and pectin con-
taining formulae (F11–F13) having n values >0.5. Increase in
the value of the exponent n indicates that the release mecha-
nism shifted from Fickian diffusion controlled to non-Fickian
diffusion mechanism.
3.8. Stability study
KT ﬂoating beads were subjected to stability studies at 25 C
with a relative humidity (RH) of 60% for a period of
6 months. After storage under these conditions, beads were
analyzed for the change in the physical appearance, drug con-
tent and ﬂoating behavior. Storage of the beads under the
studied conditions did not result in appreciable changes in
the physical properties of the all tested formulae regarding col-
or and shape via the visual inspection. Also, drug content of
the ﬂoating beads did not change till the end of six months
after storage. For ﬂoating behavior; it was observed that the
lag time was increased for F11, F12 and F13 after storage
which may be due to the matrix of these formulae; sodium algi-
nate and pectin which were not impact enough to entrap car-
bon dioxide under storage conditions and a part of carbon
dioxide was escaped which led to elongation in the lag time
but this elongation was not signiﬁcant (p > 0.05). Also it
was observed from the results that there was no change in
the duration of ﬂoating and all formulae showed ﬂoating for
more than 8 h. F1 containing sodium alginate showed also a
good stability within the time of storage with respect to the
physical and chemical changes.
3.9. Analgesic effect using hot plate method
The KT ﬂoating beads’ formula (F10) containing sodium algi-
nate/hydroxypropyl cellulose (5:1) was selected to evaluate theent kinetic models.
Higuchi model Korsmeyer-Peppas
in1) R2 K (% min1) R2 n
0.988 5.378 0.974 0.398
0.974 3.958 0.948 0.388
0.995 3.789 0.994 0.471
0.973 4.126 0.960 0.573
0.996 4.289 0.988 0.433
0.993 4.407 0.916 0.433
0.995 4.390 0.987 0.569
0.970 2.178 0.969 0.342
0.981 2.277 0.975 0.413
0.983 2.233 0.987 0.466
0.987 5.463 0.986 0.521
0.973 5.015 0.961 0.575
0.976 4.985 0.960 0.638
Ketorolac tromethamine ﬂoating beads fororal application: Characterization and in vitro/in 357in vivo analgesic effect of KT in the comparison with both the
commercial KT tablets (ketoral) and KT solution. F10 was
selected on the basis of its in vitro release proﬁle that it showed
a signiﬁcant retardation of drug release and about 60% of the
drug was released within 8 h. In addition, F10 remained buoy-
ant for >8 h and showed the highest % drug loading and also
the highest drug encapsulation efﬁciency (Table 2).
The hot plate method was described by Woolfe and Dona-
lod (1944) and Adams et al. (1969). This test was found to be
suitable for evaluating the centrally and peripherally acting
analgesics. Group I mice did not receive any medication and
considered as a control for the evaluation of analgesic effect
in the other groups. Three parameters have been utilized to as-
sess the analgesic effect of KT. These parameters are: the max-
imum response (MR) to KT in terms of the reaction time in
seconds which reﬂects the intensity of drug action, the time
of the maximum response (TMR) and the duration of drug ac-
tion (DA) which is the time through which the effect is
maintained.
Fig. 12 and Table 5 illustrated the effect of oral administra-
tion of KT solution, commercial KT tablets (Ketoral) and
the selected KT ﬂoating beads (F10) on the change of animal’s
behavior toward pain stimulant. From Fig. 12 and Table 5 it
was observed that KT solution (1.1 mg/kg) showed a signiﬁ-
cant increase of the analgesic effect (p< 0.05) in mice after
0.5 h of oral drug administration as compared to a controlTable 4 Analgesic effect of KT ﬂoating beads (F10), KT solution a
using tail-ﬂick method.
Tested groups Time of tail ﬂick test (h)
0.5 1.0 2 3
Reaction
time of analgesic
eﬀect in sec. (mean ± SE)
Group (Control) 3.5 ± 0.13 3.2 ± 0.14 4.0 ± 0.25 3.7 ± 0
Group II (KT solution) *5.2 ± 0.19 *7.8 ± 0.20 *8.2 ± 0.31 *7.7 ± 0
Group III (Ketoral) *4.1 ± 0.20 *5.5 ± 0.21 *7.3 ± 0.11 *8.4 ± 0
Group V (F10 fast) *4.3 ± 0.10 *4.6 ± 0.13 *5.7 ± 0.16 *6.3 ± 0
Group V (F10 fed) *4.4 ± 0.22 *4.2 ± 0.19 *6.4 ± 0.15 *7.5 ± 0
All values are means ± SE of six determinations.
* Indicates that a signiﬁcant increase in the analgesic effect was obtained
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Figure 12 Analgesic effect of the selected formula of KT ﬂoating
beads (F10) in fast and fed mice compared with KT solution and
Ketoral tablets using hot plate method. All values are means
± SE of six determinations.and the maximum analgesic response, MR (12.6 ± 0.55 s.)
was observed after 2 h, then it decreased gradually till disap-
pearance after 5 h.
Also Ketoral (1.1 mg/kg) showed a signiﬁcant increase of
the analgesic effect (p< 0.05) in mice after 0.5 h of oral drug
administration as compared to a control and the maximum
analgesic response, MR (13.0 ± 0.37 s.) was observed after
4 h, then it decreased gradually till disappearance after 5 h.
On the other hand, oral administration of selected KT
ﬂoating beads (F10) containing HPC (sodium alginate/HPC,
5:1) showed a signiﬁcant increase of the analgesic effect
(p< 0.05) in mice after 0.5 h of oral drug administration as
compared to a control and the maximum analgesic response,
MR (9.8 ± 0.67 s.) was seen after 4 h then it decreased gradu-
ally till disappearance after 6 h. In fed mice, F10 showed also
signiﬁcant analgesic effect (p< 0.05) after 0.5 h of oral admin-
istration and a maximum analgesic response (11.5 ± 0.67 s.)
was observed after 4 h. The duration of drug action was main-
tained for more than 8 h (Fig. 12 & Table 5). This sustained
action may be due to the lower ability of HPC to absorb ﬂuid
and swell, therefore, a long time is taken for ﬂuid to penetrate
the system, dissolve the drug then for the drug solution to dif-
fuse outwards (Borkar et al., 2010). From the results it was ob-
served that food intake had signiﬁcant effect on improving
analgesic proﬁle of the drug in mice. This phenomenon can
be explained as follows, longer residence of beads at a favor-
able site of absorption and kept it ﬂoated in the stomach for
a period of time sufﬁcient to release the drug from dense struc-
ture beads which lead to increase in the absorption of the drug.
On the other hand in the fast mice there was rapid emptying of
beads from the stomach before complete release of the drug
from dense structure of beads and this led to decrease in the
absorption of the drug (Singh and Kim, 1991).
3.10. Analgesic effect using tail ﬂick method
For further conﬁrmation of the results of analgesic effect, tail
ﬂick method was performed. Tail withdrawal time (time passed
till mice withdraw its tail from the radiant heat source) was ta-
ken as the end point. A cut off time of 10 s was used to prevent
any injury to the tail. Also group I did not receive any medica-
tion, and considered as a control for the evaluation of analge-
sic effect in other groups (Tables 4 and 5). From the tables itnd commercial KT tablets (Ketoral) in mice
4 5 6 7 8
.14 3.3 ± 0.11 3.5.±0.23 3.4 ± 0.14 3.3 ± 0.22 3.1 ± 0.18
.28 *5.0 ± 0.20 3.7 ± 0.29 3.2 ± 0.22 3.4 ± 0.18 3.5 ± 0.11
.14 *6.6 ± 0.13 *6.3 ± 0.12 *4.6 ± 0.15 3.2 ± 0.15 3.0 ± 0.21
.13 *7.5 ± 0.15 *7.3 ± 0.14 *5.1 ± 0.14 *4.5 ± 0.16 4.1 ± 0.13
.28 *7.9 ± 0.10 *7.9 ± 0.26 *7.5 ± 0.22 *7.5 ± 0.12 *7.0 ± 0.18
(p< 0.05) as compared to a control.
Table 5 Parameters of analgesic effect of KT solution, Ketoral tablets and KT ﬂoating beads (F10) in mice using hot plate and tail
ﬂick methods.
KT in Parameters of analgesic eﬀect using hot plate method Parameters of analgesic eﬀect using tail ﬂick method
MR (s) ± SE TMR (h) DA (h) MR (s) ± SE TMR (h) DA (h)
Solution 12.6 ± 0.55 2 5 8.2 ± 0.31 2 4
Ketoral 13.0 ± 0.37 4 5 8.4 ± 0.14 3 6
F10 (fast) 9.80 ± 0.67 4 6 7.5 ± 0.15 4 7
F10 (fed) 11.5 ± 0.67 4 >8 7.9 ± 0.10 4 >8
All values are means ± SE of six determinations. MR is the maximum analgesic response, TMR is the time of maximum analgesic response and
DA is the duration of analgesic action.
358 A.E.S.F. Abou el Ela et al.was observed that oral administration of KT (1.1 mg/kg) solu-
tion induced a signiﬁcant increase of the analgesic effect
(p< 0.05) in mice after 0.5 h (5.2 ± 0.19 s.) and the time of
maximum analgesic effect was seen after 2 h. All measures un-
til 4 h showed a signiﬁcant increase (p< 0.05) in the analgesic
effect when compared to a control.
Commercial oral KT tablets (Ketoral) showed the analge-
sic effect in mice for 6 h. Analgesic effect started after 0.5 h of
the drug administration (4.1 ± 0.20 s.) and time of maximum
analgesic effect was observed after 3 h. All measures until 6 h
showed a signiﬁcant increase in the analgesic effect
(p< 0.05) as compared to a control (Tables 4 and 5).
Oral administration of the selected KT (1.1 mg/kg) ﬂoating
beads (F10) in fast mice induced signiﬁcant (p< 0.05) analge-
sic effect after 0.5 h (4.3 ± 0.10) with a maximum analgesic ef-
fect after 4 h, while a maximum analgesic effect was observed
after 5 h in fed mice and its effect continued for more than 8 h
(Tables 4 and 5). From the results, it was revealed that, dura-
tion of analgesic effect induced by F10 in fed mice was doubled
compared to that induced by KT solution (group II) and it was
about 1.5 times higher than the duration of analgesic effect in-
duced by commercial KT tablets (group III). These results ob-
tained from the tail ﬂick test showed a good agreement with
those obtained from hot plate test.
4. Conclusion
In the present study ﬂoating beads of KT were formulated to
achieve sustained release of the drug. The sodium alginate
beads prepared with hydroxypropyl cellulose showed better
loading and ﬂoating characteristics and the release studies re-
vealed that the beads exhibited sustained drug release. The re-
sults obtained from tail ﬂick method showed a good agreement
with those obtained from the hot plate method and revealed
the sustained analgesic effect of the drug for more than 8 h.Acknowledgement
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